Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

PURPOSE: A randomized, placebo-controlled study based on preclinical and clinical data that supports the potential role of vascular endothelial growth factor in prostate cancer was performed to evaluate the addition of bevacizumab to standard docetaxel and prednisone therapy in patients with metasta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kelly, William Kevin, Halabi, Susan, Carducci, Michael, George, Daniel, Mahoney, John F., Stadler, Walter M., Morris, Michael, Kantoff, Philip, Monk, J. Paul, Kaplan, Ellen, Vogelzang, Nicholas J., Small, Eric J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2012
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3383121/
https://ncbi.nlm.nih.gov/pubmed/22454414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.39.4767
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados